Kyle Meury

Kyle Meury is a Corporate Access Analyst at H.C. Wainwright & Co., LLC since June 2023. Previously, Kyle held a Marketing Intern position at ERm Research LLC from June to August 2022, where responsibilities included designing market research surveys and conducting audience segmentation analyses. In the summer of 2021, Kyle interned with the commercial team at BioXcel Therapeutics, Inc., contributing to the product launch of IGALMI, an alpha-2 adrenergic receptor agonist. Kyle holds a Bachelor's degree in Marketing from the University of Maryland, obtained in 2023.